EN PL

FDA: Bioequivalence Recommendations for Specific Products

02.07.2010
This guidance describes FDA’s process for making available to the public FDA guidance on how to design bioequivalence (BE) studies for specific drug products to support abbreviated new drug applications (ANDAs).